Orchestra BioMed Holdings, Inc. – NASDAQ:OBIO
Orchestra BioMed Holdings stock price today
$2.54
-1.86
-42.27%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
Orchestra BioMed Holdings stock price monthly change
-45.88%
month
Orchestra BioMed Holdings stock price quarterly change
-45.88%
quarter
Orchestra BioMed Holdings stock price yearly change
-53.49%
year
Orchestra BioMed Holdings key metrics
Market Cap | 179.99M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -1.47 |
Revenue | 2.21M |
EBITDA | -54.35M |
Income | -51.64M |
Revenue Q/Q | -46.73% |
Revenue Y/Y | -42.15% |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | -2452.89% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeOrchestra BioMed Holdings stock price history
Orchestra BioMed Holdings stock forecast
Orchestra BioMed Holdings financial statements
| Jun 2023 | 915K | -12.04M | -1316.5% |
|---|---|---|---|
| Sep 2023 | 419K | -13.31M | -3178.04% |
| Dec 2023 | 262K | -12.81M | -4892.37% |
| Mar 2024 | 620K | -13.46M | -2171.45% |
| Sep 2025 | 700K | -13.95M | -1993.31% |
|---|---|---|---|
| Oct 2025 | 850K | -13.77M | -1620.53% |
| Dec 2025 | 200K | -19.03M | -9515.77% |
| Dec 2025 | 850K | -13.05M | -1536.34% |
Analysts Price target
Financials & Ratios estimates
| 2024-02-12 | -0.4 | -0.35827 |
|---|---|---|
| 2024-03-27 | -0.38 | -0.37 |
| 2024-05-13 | -0.4 | -0.38 |
| Jun 2023 | 125883000 | 36.44M | 28.95% |
|---|---|---|---|
| Sep 2023 | 116357000 | 36.70M | 31.54% |
| Dec 2023 | 95212000 | 27.16M | 28.54% |
| Mar 2024 | 82628000 | 25.44M | 30.79% |
| Jun 2023 | -10.49M | 8.11M | 86K |
|---|---|---|---|
| Sep 2023 | -10.28M | 12.94M | 4K |
| Dec 2023 | -10.97M | 33.15M | -10.69M |
| Mar 2024 | -13.11M | 5.86M | 18K |
Orchestra BioMed Holdings alternative data
| Feb 2024 | 4 |
|---|---|
| Mar 2024 | 4 |
| Apr 2024 | 4 |
| May 2024 | 56 |
| Jun 2024 | 56 |
| Jul 2024 | 56 |
Orchestra BioMed Holdings other data
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| May 2024 | 7000 | 0 |
| Jun 2024 | 1000 | 0 |
| Aug 2024 | 2500 | 0 |
| Sep 2024 | 10000 | 39925 |
| Dec 2024 | 10000 | 0 |
-
What's the price of Orchestra BioMed Holdings stock today?
One share of Orchestra BioMed Holdings stock can currently be purchased for approximately $2.54.
-
When is Orchestra BioMed Holdings's next earnings date?
Unfortunately, Orchestra BioMed Holdings's (OBIO) next earnings date is currently unknown.
-
Does Orchestra BioMed Holdings pay dividends?
No, Orchestra BioMed Holdings does not pay dividends.
-
How much money does Orchestra BioMed Holdings make?
Orchestra BioMed Holdings has a market capitalization of 179.99M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 21.88% to 2.76M US dollars. Orchestra BioMed Holdings made a loss 49.12M US dollars in net income (profit) last year or -$0.38 on an earnings per share basis.
-
What is Orchestra BioMed Holdings's stock symbol?
Orchestra BioMed Holdings, Inc. is traded on the NASDAQ under the ticker symbol "OBIO".
-
What is Orchestra BioMed Holdings's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Orchestra BioMed Holdings?
Shares of Orchestra BioMed Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Orchestra BioMed Holdings have?
As Jul 2024, Orchestra BioMed Holdings employs 56 workers, which is 1300% more then previous quarter.
-
When Orchestra BioMed Holdings went public?
Orchestra BioMed Holdings, Inc. is publicly traded company for more then 5 years since IPO on 4 Aug 2020.
-
What is Orchestra BioMed Holdings's official website?
The official website for Orchestra BioMed Holdings is orchestrabiomed.com.
-
Where are Orchestra BioMed Holdings's headquarters?
Orchestra BioMed Holdings is headquartered at 150 Union Square Drive, New Hope, PA.
-
How can i contact Orchestra BioMed Holdings?
Orchestra BioMed Holdings's mailing address is 150 Union Square Drive, New Hope, PA and company can be reached via phone at 215 862 5797.
Orchestra BioMed Holdings company profile:
Orchestra BioMed Holdings, Inc.
orchestrabiomed.comExchange:
NASDAQ
Full time employees:
56
Industry:
Biotechnology
Sector:
Healthcare
Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold retractors that are minimally invasive surgical device solutions. The company has a strategic collaboration with Medtronic for the development and commercialization of BackBeat CNT for the treatment of hypertension in pacemaker-indicated patients; and a strategic partnership with Terumo Corporation for the development and commercialization of Virtue SAB for the treatment of artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.
150 Union Square Drive
New Hope, PA 18938
New Hope, PA 18938
CIK: 0001814114
ISIN: US68572M1062
CUSIP: 68572M106
